FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086552186> ?p ?o ?g. }

• W2086552186 endingPage "387" @default.
• W2086552186 startingPage "383" @default.
• W2086552186 abstract "Objective The chimeric anti-tumor necrosis factor-α antibody infliximab is known to induce antibodies-to-infliximab (ATI) in some treated patients. Immunogenicity in murine variable domains is expected; however, constant domains of its human heavy γ1 chain may also be implicated as it expresses G1m1 and G1m17 allotypes. This allelic form may be immunogenic in patients that are homozygous for the G1m3 allotype commonly expressed in Caucasoid populations. Methods As G1m allotypic divergence may explain the presence of ATI or may influence their concentration, a genotyping method was developed and validated to determine antithetical (i.e. mutually exclusive) G1m3 and G1m17 allotypes (amino acid 120 of CH1 according to the international ImMunoGeneTics information system unique numbering) at the IGHG1 gene level (CH1 359g/a nucleotide polymorphism). Two hundred forty-five blood donors and 118 previously described patients suffering from Crohn's disease, treated with infliximab, and having developed ATI in 73 of them, were genotyped. Results The IGHG1 CH1 359g/a polymorphism does not depart from the Hardy–Weinberg equilibrium in the control population, and allele frequencies were similar in controls and patients. No association was found between the patient G1m allotypes and the presence of ATI or their concentration. It remains possible that anti-Gm1 antibodies are not well detected by the enzyme-linked immunosorbent assays used for ATI detection and/or that the G1m allotypes are minor antigens on IgG1. Conclusion The IGHG1 polymorphism does not seem to play a major role in the induction of ATI. Further analyses will be required to determine whether it is also the case for humanized or fully human antibodies bearing the same G1m allotypes." @default.
• W2086552186 created "2016-06-24" @default.
• W2086552186 creator A5011831250 @default.
• W2086552186 creator A5019474609 @default.
• W2086552186 creator A5022022076 @default.
• W2086552186 creator A5028831197 @default.
• W2086552186 creator A5044430523 @default.
• W2086552186 creator A5045465014 @default.
• W2086552186 creator A5052113690 @default.
• W2086552186 creator A5061145057 @default.
• W2086552186 creator A5066851139 @default.
• W2086552186 creator A5070209121 @default.
• W2086552186 creator A5070576395 @default.
• W2086552186 creator A5071797672 @default.
• W2086552186 creator A5086098057 @default.
• W2086552186 date "2009-05-01" @default.
• W2086552186 modified "2023-10-11" @default.
• W2086552186 title "IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab" @default.
• W2086552186 cites W1706639446 @default.
• W2086552186 cites W1964522754 @default.
• W2086552186 cites W1978651681 @default.
• W2086552186 cites W1995177703 @default.
• W2086552186 cites W1997999969 @default.
• W2086552186 cites W2006174096 @default.
• W2086552186 cites W2017883234 @default.
• W2086552186 cites W2018600081 @default.
• W2086552186 cites W2029667189 @default.
• W2086552186 cites W2082947088 @default.
• W2086552186 cites W2086415546 @default.
• W2086552186 cites W2096387523 @default.
• W2086552186 cites W2141139109 @default.
• W2086552186 cites W2164894510 @default.
• W2086552186 cites W2166771071 @default.
• W2086552186 cites W2253414912 @default.
• W2086552186 cites W4250776648 @default.
• W2086552186 doi "https://doi.org/10.1097/fpc.0b013e32832a06bf" @default.
• W2086552186 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19319024" @default.
• W2086552186 hasPublicationYear "2009" @default.
• W2086552186 type Work @default.
• W2086552186 sameAs 2086552186 @default.
• W2086552186 citedByCount "70" @default.
• W2086552186 countsByYear W20865521862012 @default.
• W2086552186 countsByYear W20865521862013 @default.
• W2086552186 countsByYear W20865521862014 @default.
• W2086552186 countsByYear W20865521862015 @default.
• W2086552186 countsByYear W20865521862016 @default.
• W2086552186 countsByYear W20865521862017 @default.
• W2086552186 countsByYear W20865521862018 @default.
• W2086552186 countsByYear W20865521862019 @default.
• W2086552186 countsByYear W20865521862020 @default.
• W2086552186 countsByYear W20865521862021 @default.
• W2086552186 countsByYear W20865521862022 @default.
• W2086552186 countsByYear W20865521862023 @default.
• W2086552186 crossrefType "journal-article" @default.
• W2086552186 hasAuthorship W2086552186A5011831250 @default.
• W2086552186 hasAuthorship W2086552186A5019474609 @default.
• W2086552186 hasAuthorship W2086552186A5022022076 @default.
• W2086552186 hasAuthorship W2086552186A5028831197 @default.
• W2086552186 hasAuthorship W2086552186A5044430523 @default.
• W2086552186 hasAuthorship W2086552186A5045465014 @default.
• W2086552186 hasAuthorship W2086552186A5052113690 @default.
• W2086552186 hasAuthorship W2086552186A5061145057 @default.
• W2086552186 hasAuthorship W2086552186A5066851139 @default.
• W2086552186 hasAuthorship W2086552186A5070209121 @default.
• W2086552186 hasAuthorship W2086552186A5070576395 @default.
• W2086552186 hasAuthorship W2086552186A5071797672 @default.
• W2086552186 hasAuthorship W2086552186A5086098057 @default.
• W2086552186 hasConcept C104317684 @default.
• W2086552186 hasConcept C135763542 @default.
• W2086552186 hasConcept C1547928 @default.
• W2086552186 hasConcept C159654299 @default.
• W2086552186 hasConcept C17991360 @default.
• W2086552186 hasConcept C180754005 @default.
• W2086552186 hasConcept C203014093 @default.
• W2086552186 hasConcept C2777138892 @default.
• W2086552186 hasConcept C2780889450 @default.
• W2086552186 hasConcept C2908647359 @default.
• W2086552186 hasConcept C31467283 @default.
• W2086552186 hasConcept C54355233 @default.
• W2086552186 hasConcept C71924100 @default.
• W2086552186 hasConcept C76252995 @default.
• W2086552186 hasConcept C86803240 @default.
• W2086552186 hasConcept C99454951 @default.
• W2086552186 hasConceptScore W2086552186C104317684 @default.
• W2086552186 hasConceptScore W2086552186C135763542 @default.
• W2086552186 hasConceptScore W2086552186C1547928 @default.
• W2086552186 hasConceptScore W2086552186C159654299 @default.
• W2086552186 hasConceptScore W2086552186C17991360 @default.
• W2086552186 hasConceptScore W2086552186C180754005 @default.
• W2086552186 hasConceptScore W2086552186C203014093 @default.
• W2086552186 hasConceptScore W2086552186C2777138892 @default.
• W2086552186 hasConceptScore W2086552186C2780889450 @default.
• W2086552186 hasConceptScore W2086552186C2908647359 @default.
• W2086552186 hasConceptScore W2086552186C31467283 @default.
• W2086552186 hasConceptScore W2086552186C54355233 @default.
• W2086552186 hasConceptScore W2086552186C71924100 @default.
• W2086552186 hasConceptScore W2086552186C76252995 @default.
• W2086552186 hasConceptScore W2086552186C86803240 @default.

• next